ZYMOGESIC TABLET is a combination of Bromelain, Rutoside, and Trypsin, which belongs to the group of medicines called Proteolytic enzymes and Flavonoids, respectively. It is used in the management of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, gout, joint issues related to inflammation, pain and swelling of joints, swelling associated with surgical wounds, pulmonary edema, ulcerative colitis, sports and accidental injuries, muscular cramps and spasms, tendinitis, bursitis, dental extraction, sinusitis, bronchitis, and rhinitis. 

Prior to starting the management with ZYMOGESIC TABLET, your doctor might want you to take several diagnostic tests to understand your existing condition and to safely use this medicine to manage the risk of any unusual effects. 

ZYMOGESIC TABLET is not recommended for use in patients with hemophilia (a disorder in which blood doesn't clot normally), liver or kidney disorders, or patients undergoing haemodialysis. ZYMOGESIC TABLET should be taken with caution in patients with any bleeding disorders and heart disease. 

ZYMOGESIC TABLET is not recommended for use in pregnant and breastfeeding women. There is no data on the use of ZYMOGESIC TABLET in children or elderly patients; hence, always consult your doctor for advice before taking this medicine. 

The most common side effects of taking ZYMOGESIC TABLET are nausea, diarrhea, stomach upset, tiredness, dry mouth, and skin rash. Consult your doctor if any of the side effects worsen.